Pennington Partners & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Pennington Partners & Co's LLY Position: Q3 2026 in Review
Pennington Partners & Co reduced its Eli Lilly (LLY) stake by 5.7% in Q3 2026, selling an estimated $46K and leaving 642 shares worth $742K. The position accounts for 0.24% of the portfolio, ranked #51.
Pennington Partners & Co first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $817K in Q2 2026. 4,590 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Pennington Partners & Co held 642 shares of Eli Lilly worth $742K as of Q3 2026.
- Pennington Partners & Co sold 39 Eli Lilly shares in Q3 2026, an estimated $46K.
- Eli Lilly made up 0.24% of Pennington Partners & Co's portfolio in Q3 2026, its #51 holding.
- Pennington Partners & Co first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Pennington Partners & Co's Eli Lilly position peaked at $817K in Q2 2026.
- 4,590 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Pennington Partners & Co's 13F filing for Q3 2026, filed 13 Nov 2026.